Notable Labs Ltd - Bathi mangsa ngarep NTBL

NTBL (Notable Labs Ltd) - tandha merek perusahaan

Niche concentration on IT-based oncotherapy forecasting creates binary risks for Notable Labs, Ltd. (NTBL). Geopolitics complicates patent protection and component supplies. However, the uniqueness of the tests allows the company to exercise pricing power, which supports the consensus profit forecast for Notable Labs, Ltd. (NTBL). The current metric determines the parameter status, reflecting analysts' expectations for the business's financial results on the chart.

NTBL: Bathi mangsa ngarep notablelabs.com 04.07.2022 - 17.11.2026

Notable Labs Inc. - rincian analitis lan metrik utama (NTBL)

- rega lan prakiraan konsensus rega:
Analisis fundamental perusahaan:NTBL, Notable Labs Inc.
Barang utama Notable Labs Ltd

Notable Labs, Ltd. (NTBL) is developing a patent-protected AI platform for personalized oncology that relies on unique cellular data sets. The projected profit model accounts for these barriers to entry, transforming technological potential into expected cash flows. This metric measures the business's ability to scale diagnostic methods and monetize intellectual property. It is critical for investors to evaluate the trend of expectations regarding the asset's market value. Analyzing the company's future profit chart helps determine the startup's fair valuation point.

Perusahaan pesaing

Bathi mangsa ngarep ONC|HALO: Penghasilan resik sing dikarepake|Bathi mangsa ngarep RVMD (RevMed)|AAPG (Ascentage) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep CGON (cgoncology.com)|URGN - Bathi mangsa ngarep|BCAX: Bathi mangsa ngarep|PSNL - Proyeksi bathi mangsa ngarep|Erasca Corp (ERAS) - Bathi sing dikarepake|Delcath - Penghasilan resik sing dikarepake|YMAB (Y-mAbs Therapeutics Inc) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake Aura Biosciences, Inc. AURA|Proyeksi bathi mangsa ngarep CADL|Proyeksi bathi mangsa ngarep Accuray (ARAY)|Bathi sing dikarepake SELLAS Life Sciences Group Inc. SLS|ACTU - Bathi mangsa ngarep|CTOR: Bathi mangsa ngarep|Penghasilan resik sing dikarepake HURA (TuHURA Biosciences Inc.)|TARA (Protara Therapeutics) - Bathi mangsa ngarep|Bathi resik sing dikarepake Fate Therapeutics Corp (FATE)|Bathi mangsa ngarep WHWK|Prakiraan bathi resik TCRX (TScan Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep CSBR|XBIT - Bathi resik sing dikarepake|CEL-SCI Corporation - Bathi mangsa ngarep|Penghasilan resik sing dikarepake OSTX|radiopharmtheranostics.com - Proyeksi bathi mangsa ngarep|ARTV: Bathi sing dikarepake|ANL (adlainortye.com) - Bathi mangsa ngarep|VERU - Prakiraan bathi perusahaan|TPST (Tempest Therapeutics, Inc.) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep xiliotx.com|Bathi sing dikarepake Enochian BioSciences (RENB)|Bathi sing dikarepake MURA (Mural Oncology PLC)|Bathi sing dikarepake Kairos Pharma Ltd KAPA|Proyeksi bathi mangsa ngarep OnKure Therapeutics Inc OKUR|CytoMed Therapeutics - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Curis CRIS|APLM: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep Tharimmune, Inc.|ADVB (Advanced Biomed) - Proyeksi bathi mangsa ngarep|Genprex - Bathi forward|Bathi sing dikarepake calidibio.com (CLDI)|SBFM (Sunshine Biopharma Inc.) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XBIO (Xenetic Biosciences)|Salarius Pharmaceuticals (SLRX) - Bathi resik sing dikarepake|PPBT: Bathi mangsa ngarep|Penghasilan resik sing dikarepake AONC (American Oncology Network, Inc.)|BeOne Medicines (BGNE) - Bathi sing dikarepake|Checkpoint Therapeutics, Inc (CKPT) - Proyeksi bathi mangsa ngarep|Bathi sing dikarepake Elevation Oncology, Inc.|ICAD: Penghasilan resik sing dikarepake|Bathi sing dikarepake ikenaoncology.com (IKNA)|Bathi sing dikarepake VIRX (Viracta Therapeutics, Inc.)|Proyeksi bathi mangsa ngarep MOR (MorphoSys Inc)|Proyeksi bathi mangsa ngarep NAYA Biosciences Inc NAYA|AAPGV - Bathi sing dikarepake